hero image
Paulina Hill - Consulate General of Canada (CTA Boston). Cambridge, MA, US

Paulina Hill

Principal | Omega Funds

Cambridge, MA, UNITED STATES

Paulina Hill is a healthcare investor who has expertise in biotechnology, molecular biology, cell culture and entrepreneurship.

Social

Biography

Paulina was on the healthcare team at Polaris Partners since 2012, and is now a Biotech investor at Omega Funds. Paulina is currently an observer on the board of Arrakis Therapeutics. Paulina previously served on the boards of Kala Pharmaceuticals (NASDAQ: KALA), Neuronetics (NASDAQ: STIM), Lyra Pharmaceuticals, Faraday Pharmaceuticals, Arsenal Medical and CAMP4 Therapeutics, where she was the founding CEO. Paulina completed her postdoctoral fellowship in Robert Langer’s lab in the Chemical Engineering department at the Massachusetts Institute of Technology. Paulina was the founding president of the MIT Postdoctoral Association and served on the MIT Intellectual Property Presidential Committee. Paulina completed her PhD in Molecular Medicine from the Wake Forest University School of Medicine and graduated magna cum laude from East Carolina University with a quadruple major in biochemistry, neuroscience, biology and chemistry.

Industry Expertise (2)

Pharmaceuticals

Biotechnology

Areas of Expertise (6)

Venture Capital

Chemistry

Technology Transfer

Biochemistry

Lifesciences

Molecular Biology

Education (3)

Massachussetts Institute of Technology: Postdoctoral Fellowship, Chemical Engineering 2011

Wake Forest University School of Medicine: Ph.D, Molecular Medicine 2009

East Carolina University: B.S./B.A., Biochemistry/Neuroscience/Biology 2004